GutSystems BiologyPeer-reviewed journal article
Integrated multi-model analysis of intestinal inflammation exposes key molecular features of preclinical and clinical IBD
Miguel González-AceraiD, Jay V. PatankariD, Lena Erkert, Roodline CineusiD, Reyes Gámez‐BelmonteiD, Tamara LeupoldiD, Marvin BubeckiD, Li-Li Bao, Martin Dinkel, Ru Wang, Laura Schickedanz, Heidi Limberger, Iris Stolzer, Katharina GerlachiD, Leonard Diemand, Fabrizio Mascia, Pooja GuptaiD, Elisabeth NaschbergeriD, Kristina KoopiD, Christina PlattneriD, Gregor SturmiD, Benno WeigmanniD, Claudia GüntheriD, Stefan J. WirtziD, Michael StürzliD, , Christoph BeckeriD
- Citations
- 18
- FWCI
- 10.53
- Field percentile
- top 1%
Abstract
BackgroundInflammatory bowel disease (IBD) is a chronic inflammatory condition of the intestine with a complex and multifaceted pathogenesis. While various animal models exist to study specific disease mechanisms relevant to human IBD, a comprehensive comparative framework linking these to IBD pathophysiology is lacking. ObjectiveIn our study, we aimed at providing a framework that delineates common and unique features encountered in 13 widely used mouse models comparing them with human IBD to identify translatable pathways in model-cohort pairs. Another aim of our study was to provide an explorable resource for looking up gene and pathway level changes in mouse models assisting in hypothesis testing and minimizing animal burden abiding by the 3R principals. DesignWe employed comparative transcriptomic analyses with curated and a priori statistical correlative methods between mouse models versus established as well as own patient datasets at both bulk and single cell levels. ResultsWe identify IBD-related pathways, ontologies, and cellular processes that are translatable between mouse models and patient cohorts. Moreover, we identify, known and novel IBD-associated subcellular mechanisms and how they are recapitulated in specific mouse models. ConclusionOur findings provide a valuable resource for selecting the most appropriate experimental paradigm to model unique features of IBD pathomechanisms, allowing analysis at the tissue, cellular, and subcellular levels. What is already known on this topicPreclinical modelling of IBD is key to the discovery of pathomechanisms and the evaluation of therapeutic approaches. However, individual models do not recapitulate the complexity of the disease and comprehensive studies comparing modelling paradigms with human IBD are lacking. What this study addsOur study provides a comparative analysis of thirteen commonly used intestinal inflammation models, identifying core-conserved pathways between mouse models and IBD patient cohorts. In addition, our study shows how specific pathways involved in IBD are recapitulated in specific mouse models and introduces a web tool to analyse the models. How this study might affect research, practice or policyBy identifying conserved and discrepant pathways between specific mouse models and IBD patient cohorts, our analysis platform provides an invaluable resource for translational IBD research.
- organism: mouse
- assay: bulk RNA-seq
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: database / resource
- approach: statistical model
- approach: benchmark study
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic and dietary modulators of the inflammatory response in the gastro-intestinal tract of the BXD mouse genetic reference population
Xiaoxu Li, Jean‐David Morel, … Johan H. Auwerx·bioRxiv·Mar 22, 2023
- Mouse Adaptation of Human Inflammatory Bowel Diseases Microbiota Enhances Colonization Efficiency and Alters Microbiome Aggressiveness Depending on Recipient Colonic Inflammatory Environment
S. M. Gray, A. D. Moss, … R. B. Sartor·bioRxiv·Jan 23, 2024
- High-Throughput Human Gut Immune Co-Culture Model for Evaluating Inflammatory Bowel Disease Anti-Inflammatory Therapies
Swetha Peddibhotla, Lauren A. Boone, … Elizabeth M. Boazak·bioRxiv·May 14, 2025
- Intestinal inflammation and altered gut microbiota associated with inflammatory bowel disease renders mice susceptible to Clostridioides difficile colonization and infection
L. Abernathy Close, M. R. Barron, … V. B. Young·bioRxiv·Jul 30, 2020
- Inflammatory bowel disease microbiotas alter gut CD4 T-cell homeostasis and drive colitis in mice
Graham J. Britton, Eduardo J. Contijoch, … Jeremiah J. Faith·bioRxiv·Mar 6, 2018
- Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease
S. Hu, A. R. Bourgonje, … R. K. Weersma·bioRxiv·Jun 4, 2022